Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/46967
Title: | Middle-term outcomes in renal transplant recipients with COVID-19: a national, multicenter, controlled study | Authors: | Oto, Ozgur Akin Ozturk, Savas Arici, Mustafa Velioglu, Arzu Dursun, Belda Guller, Nurana Sahin, Idris Eser, Zeynep Ebru Paydas, Saime Trabulus, Sinan Koyuncu, Sumeyra Uyar, Murathan Ural, Zeynep Sadioglu, Rezzan Eren Dheir, Hamad Koc, Neriman Sila Ozer, Hakan Durak, Beyza Algul Gul, Cuma Bulent Kasapoglu, Umut Oguz, Ebru Gok Tanrisev, Mehmet Kuzgun, Gulsah Sasak Mirioglu, Safak Dervisoglu, Erkan Erken, Ertugrul Gorgulu, Numan Ozkurt, Sultan Aydin, Zeki Kurultak, ilhan Ogutmen, Melike Betul Bakirdogen, Serkan Kaya, Burcu Karadag, Serhat Ulu, Memnune Sena Gungor, Ozkan Bakir, Elif Ari Odabas, Ali Riza Odabas, Ali Riza Yildiz, Alaattin Ates, Kenan |
Keywords: | COVID-19 kidney transplantation mortality outcome registry |
Publisher: | Oxford Univ Press | Abstract: | Background In this study, we evaluated 3-month clinical outcomes of kidney transplant recipients (KTR) recovering from COVID-19 and compared them with a control group. Method The primary endpoint was death in the third month. Secondary endpoints were ongoing respiratory symptoms, need for home oxygen therapy, rehospitalization for any reason, lower respiratory tract infection, urinary tract infection, biopsy-proven acute rejection, venous/arterial thromboembolic event, cytomegalovirus (CMV) infection/disease and BK viruria/viremia at 3 months. Results A total of 944 KTR from 29 different centers were included in this study (523 patients in the COVID-19 group; 421 patients in the control group). The mean age was 46 +/- 12 years (interquartile range 37-55) and 532 (56.4%) of them were male. Total number of deaths was 8 [7 (1.3%) in COVID-19 group, 1 (0.2%) in control group; P = 0.082]. The proportion of patients with ongoing respiratory symptoms [43 (8.2%) versus 4 (1.0%); P Conclusion The prevalence of ongoing respiratory symptoms increased in the first 3 months post-COVID in KTRs who have recovered from COVID-19, but mortality was not significantly different. | URI: | https://doi.org/10.1093/ckj/sfac045 https://hdl.handle.net/11499/46967 |
ISSN: | 2048-8505 2048-8513 |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Files in This Item:
File | Size | Format | |
---|---|---|---|
sfac045.pdf | 1.8 MB | Adobe PDF | View/Open |
CORE Recommender
SCOPUSTM
Citations
3
checked on Oct 13, 2024
WEB OF SCIENCETM
Citations
3
checked on Oct 31, 2024
Page view(s)
44
checked on Aug 24, 2024
Download(s)
26
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.